Quercetin ameliorates experimental autoimmune myocarditis in rats

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 13, Issue 3, 2010, Pages 311-319

  Marina, Milenković ^a   Nevena, Arsenović Ranin ^a   Zorica, Stojić Vukanić ^a   Biljana, Bufan ^a   Dragana, Vučićević ^a   Ivan, Jančić ^a  

^a Faculty of Pharmacy   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; QUERCETIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD LEVEL; BODY WEIGHT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG DOSE COMPARISON; HEART WEIGHT; HISTOPATHOLOGY; LYMPH NODE CELL; MALE; MYOCARDITIS; NONHUMAN; RAT; UPREGULATION;

EID: 78650400220     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j3vs3s     Document Type: Article

References (44)

1. Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators, N Engl J Med 1995; 333(5):269- 275.
2. D'Ambrosio A, Patti G, Manzoli A, Sinagra G, Di Lenarda A, Silvestri F, Di Sciascio G. The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 2001; 85(5):499- 504.
3. Kim KS, Hufnagel G, Chapman NM, Tracy S.The group B coxsackieviruses and myocarditis. Rev Med Virol 2001; 11(6):355-368.
4. Caforio AL, Mahon NJ, Tona F, McKenna WJ. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur J Heart Fail 2002; 4(4):411-417.
5. Rose NR. Myocarditis: infection versus autoimmunity. J Clin Immunol 2009; 29:730-737.
6. Kodama M, Hanawa H, Saeki M, Hosono H, Inomata T, Suzuki K, Shibata A. Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. Circ Res 1994; 75(2):278-284.
7. Dimitrijević M, Milenković M, Milosavljević P, Stojić-Vukanić Z, Čolić M, Bartlett R. Beneficial effects of leflunomide on cardiac myosin-induced experimental autoimmune myocarditis in rats. Int J Immunotherapy 1998; XIV(1):9-21.
8. Okura Y, Yamamoto T, Goto S, Inomata T, Hirono S, Hanawa H, Feng L, Wilson CB, Kihara I, Izumi T, Shibata A, Aizawa Y, Seki S, Abo T. Characterization of cytokine and iNOS mRNA expression in situ during the corse of experimental autoimmune myocarditis in rats. J Moll Cell Cardiol 1997; 29:491-502.
9. Afanasyeva M, ang Y, Kaya Z, Stafford EA, Dohmen KM, Sadighi Akha AA, Rose NR. Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-gammaindependent pathway. Circulation 2001; 104(25):3145-3151.
10. Sonderegger I, Röhn TA, Kurrer MO, Iezzi G, Zou Y, Kastelein RA, Bachmann MF, Kopf M. Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis. Eur J Immunol 2006;36(11):2849-2856.
11. McGeachy MJ, Cua DJ. Th17 cell differentiation: the long and winding road. Immunity 2008; 28(4):445-453.
12. Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S, Sudo K, Iwakura Y. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. JImmunol 2006; 177(1):566-573.
13. Rangachari M, Mauermann N, Marty RR, Dirnhofer S, Kurrer MO, Komnenovic V, Penninger JM, Eriksson U. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J Exp Med 2006; 203(8):2009-2019.
14. Chang H, Hanawa H, Yoshida T, Hayashi M, Liu H, Ding L, Otaki K, Hao K, Yoshida K, Kato K, Toba K, Kodama M, Maruyama H, Miyazaki J, Aizawa Y. Alteration of IL-17 related protein expressions in experimental autoimmune myocarditis and inhibition of IL-17 by IL-10-Ig fusion gene transfer. Circ J 2008; 72(5):813-819.
15. Hollman PC, Katan MB. Health effects and bioavailability of dietary flavonols. Free Radic Res 1999; 31:75-80.
16. Ross JA, Kasum CM. Dietary flavonoids: ioavailability, metabolic effects, and safety. Annu Rev Nutr 2002; 22:19-34.
17. Knekt P, Kumpulainen J, Järvinen R, Rissanen H, Heliövaara M, Reunanen A, Hakulinen T, Aromaa A. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 2002; 76(3):560-568.
18. Rice-Evans C, Spencer JP, Schroeter H, Rechner AR. Bioavailability of flavonoids and potentialbioactive forms in vivo. Drug Metabol Drug Interact 2000; 17:291-310.
19. Guardia T, Rotelli AE, Juarez AO, Pelzer LE. Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Farmaco 2001; 56(9):683- 687.
20. Rotelli AE, Guardia T, Juárez AO, de la Rocha NE, Pelzer LE. Comparative study of flavonoids in experimental models of inflammation. Pharmacol Res 2003; 48(6):601-606.
21. Camuesco D, Comalada M, Rodríguez-Cabezas ME, Nieto A, Lorente MD, Concha A, Zarzuelo A, Gálvez J. The intestinal anti-inflammatoryeffect of quercitrin is associated with an inhibition in iNOS expression. Br J Pharmacol 2004; 143(7):908-918.
22. Verbeek R, van Tol EA, van Noort JM. Oral flavonoids delay recovery from experimental autoimmune encephalomyelitis in SJL mice. Biochem Pharmacol 2005; 70(2):220-228.
23. Hendriks JJ, Alblas J, van der Pol SM, van Tol EA, Dijkstra CD, de Vries HE. Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis. J Exp Med 2004; 200(12):1667-1672.
24. Cho SY, Park SJ, Kwon MJ, Jeong TS, Bok SH, Choi WY, Jeong WI, Ryu SY, Do SH, Lee CS, Song JC, Jeong KS. Quercetin suppresse s Proinfl ammatory cytokines production throughMAP kinases and NF-kappaB pathway in lipopolysaccharide-stimulated macrophage. Mol Cell Biochem 2003; 243(1-2):153-160.
25. Nair MP, Mahajan S, Reynolds JL, Aalinkeel R, Nair H, Schwartz SA, Kandaswami C. The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) geneexpression in normal peripheral blood mononuclear cells via modulation of the NF-kappabeta system. Clin Vaccine Immunol 2006; 13(3):319-328.
26. Xagorari A, Papapetropoulos A, Mauromatis A,Economou M, Fotsis T, Roussos C Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages. J Pharmacol Exp Ther 2001; 296(1):181-187.
27. Kodama M, Matsumoto Y, Fujiwara M, Masani F, Izumi T, Shibata A. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol 1990; 57:250-262.
28. Milenković M, Vučićević D, Milosavljević P, Arsenović-Ranin N, Stojić-Vukanić Z, Čolić M. Suppression of experimental autoimmune myocarditis by sodium fusidate (fusidin). Pharmacol Res 2005; 52:491-496.
29. Dunnick JK, Hailey JR. Toxicity and carcinogenicity studies of quercetin, a naturalcomponent of foods. Toxicol Sci 1992; 19(3):423- 431.
30. Hubbard GP, Wolffram S, Lovegrove JA, Gibbins JM Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans. J Thromb Haemost 2004; 2(12):2138- 2145.
31. Di Marco R, Khademi M, Wallstrom E, Muhallab S, Nicoletti F, Olsson T. Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): suppression of IFN-gamma and TNFalpha and enhancement of IL-10. J Autoimmun 1999; 13(2):187-195.
32. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000; 343(19):1388-1398.
33. Lane JR, Neumann DA, Lafond-Walker A, Herskowitz A, Rose NR. Interleukin 1 or tumor necrosis factor can promote Coxsackie virusinduced myocarditis in resistant B10.A mice. J Exp Med 1992; 175:1123-1129.
34. Smith SC, Allen PM. Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis. Circ Res 1992; 70(4):856-863.
35. Bachmaier K, Pummerer C, Kozieradzki I, Pfeffer K, Mak TW, Neu N, Penninger JM. Lowmolecular- weight tumor necrosis factor receptor p55 controls induction of autoimmune heart disease. Circulation 1997; 95(3):655-661.
36. Hegewisch S, Weh HJ, Hossfeld DK. TNFinduced cardiomyopathy. Lancet 1990;335(8684):294-305.
37. Yoshida T, Hanawa H, Toba K, Watanabe H, Watanabe R, Yoshida K, Abe S, Kato K, Kodama M, Aizawa Y. Expression of immunological molecules by cardiomyocytes and inflammatory and interstitial cells in rat autoimmune myocarditis. Cardiovasc Res 2005; 68(2):278-288.
38. Chang H, Hanawa H, Liu H, Yoshida T, Hayashi M, Watanabe R, Abe S, Toba K, Yoshida K, Elnaggar R, Minagawa S, Okura Y, Kato K, Kodama M, Maruyama H, Miyazaki J, Aizawa Y. Hydrodynamic-based delivery of an interleukin- 22-Ig fusion gene ameliorates experimental autoimmune myocarditis in rats. J Immunol 2006; 177(6):3635-3643.
39. Watanabe K, Nakazawa M, Fuse K, Hanawa H, Kodama M, Aizawa Y, Ohnuki T, Gejyo F, Maruyama H, Miyazaki J. Protection against autoimmune myocarditis by gene transfer of interleukin-10 by electroporation. Circulation 2001; 104(10):1098-1100.
40. Nishio R, Matsumori A, Shioi T, Ishida H, Sasayama S.Treatment of experimental viral myocarditis with interleukin-10. Circulation 1999; 100(10):1102-1108.
41. Yang S, Li W, Liu W, Gao C, Zhou B, Li S, Li Y, Kong Y. IL-10 gene modified dendritic cells induced antigen-specific tolerance in experimental autoimmune myocarditis. Clin Immunol 2006; 121(1):63-73.
42. Mathur AN, Chang HC, Zisoulis DG, Stritesky GL, Yu Q, O'Malley JT, Kapur R, Levy DE, Kansas GS, Kaplan MH. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J Immunol 2007; 178(8):4901-4907.
43. Valaperti A, Marty RR, Kania G, Germano D, Mauermann N, Dirnhofer S, Leimenstoll B, Blyszczuk P, Dong C, Mueller C, Hunziker L, Eriksson U. CD11b+ monocytes abrogate Th17 D4+ T cell-mediated experimental autoimmune myocarditis. J Immunol 2008; 180(4):2686-2695.
44. Eriksson U, Kurrer MO, Sebald W, Brombacher F, Kopf M. Dual role of the IL-12/IFN-gamma axis in the development of autoimmune yocarditis: induction by IL-12 and protection by IFN-gamma. J Immunol 2001; 167(9):5464-5469.